Institutional members access full text with Ovid®

Share this article on:

Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?

Kaufman, David I. DO; Friedman, Deborah I. MD, MPH

Section Editor(s): Lee, Andrew G. MD; Van Stavern, Gregory MD

Journal of Neuro-Ophthalmology: June 2017 - Volume 37 - Issue 2 - p 182–186
doi: 10.1097/WNO.0000000000000513
Point Counter-Point